Participate in On Demand Activity
	Activity Details PDF
	Course Materials PDF (online credit only)
	Download Slides
	Subscribe to Podcast
	Download MP3 File
	Complete Post-Test/ Print CE Certificate

	Faculty
	Statement of Need
	Activity Goal
	Learning Objectives
	Target Audience
	Financial Support
	Credit Information

neuroscienceCME Webcast

Premiere Date: Wednesday, March 24, 2010

This activity offers CE credit for:

1. Physicians (ACCME/AMA PRA Category 1)
2. Nurses (CNE)
3. Pharmacists (ACPE)
4. Psychologists (APA)
5. Social Workers (NASW)
6. Certified Case Managers (CCMC)

All other clinicians will either receive a CME Attendance Certificate or may choose any of the types of CE credit being offered.
Credit Expiration Date:
Thursday, March 24, 2011

Faculty

Cynthia L. Harden, MD  Professor of Neurology, Clinical Educator Track Director of Epilepsy Division University of Miami Miller School of Medicine Miami, FL

Michael R. Sperling, MD  Baldwin Keyes Professor of Neurology Director, Jefferson Comprehensive Epilepsy Center Thomas Jefferson University Philadelphia, PA

Vicenta Salanova, MD, FAAN (Content/Peer Reviewer) Professor of Neurology Indiana University School of Medicine Director, Indiana University Comprehensive Epilepsy Program Bloomington, IN

Statement of Need

Does having a seizure mean epilepsy, or is it an isolated neurological event? Failure to recognize diagnostic uncertainty between the epilepsies and non-epileptic events may be a factor in high rates of misdiagnosis.(1) Many patients who have been misdiagnosed as having epilepsy have had previous EEGs interpreted as epileptiform that contributed to the misdiagnosis of epilepsy.(2) Patients are often faced with the need to tolerate complex cocktails of medications over long periods of time causing side effects of these chronic medications to be of concern for both physicians and their patients. Pharmacologic management of patients with epilepsy is one of the greatest unmet needs of the disease. It is important that clinicians are aware of the evidence for current and emerging therapies so they can individualize care of their patients. There is no real "Gold Standard" of guidelines for improving diagnosis and treatment of epilepsy,(3) but clinicians need to be aware of the most recent guidelines and how they can incorporate them in their practice. In this neuroscienceCME webcast, the experts will explore these clinical challenges of managing patients with epilepsy, and will provide insights and strategies for the improvement of patient care.

---

1. Beach R, Reading R. The importance of acknowledging clinical uncertainty in the diagnosis of epilepsy and non-epileptic events. Arch Dis Child 2005;90:1219-1222.
2. Benbadis S. The differential diagnosis of epilepsy: a critical review. Epilepsy Behav 2009;15:15-21.
3. Hayes SM, Melin JD, Dupuis M, Murray S, Labiner DM. Assessing the true learning needs of health care professionals in epilepsy care. Epilepsy Behav 2007;11:434-441.

Activity Goal

To highlight the latest evidence for current and emerging treatments and translate guidelines into improved care of patients with epilepsy.

Learning Objectives

At the end of this CE activity, participants should be able to:

• Recognize the symptoms of epilepsy and list the components required to make an accurate diagnosis.
• Demonstrate improved expertise in the pharmacologic management of patients with epilepsy.
• Translate available guidelines for the treatment of epilepsy into clinical practice.

The following learning objectives pertain only to those requesting CNE credit:

• Recognize the symptoms of epilepsy.
• Identify available guidelines for the treatment of epilepsy.

Target Audience

Neurologists, epileptologists, other physicians, physician assistants, nurses, nurse practitioners, psychologists, pharmacists, social workers, certified case managers, and other healthcare professionals interested in the improvement of healthcare for patients with epilepsy.

Financial Support

This activity is supported by an unrestricted educational grant from Pfizer Inc.

Credit Information

CME Credit (Physicians):
Indiana University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Indiana University School of Medicine designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Note to Physician Assistants: AAPA accepts Category I credit from AOACCME, Prescribed credit from AAFP, and AMA Category I CME credit for the PRA from organizations accredited by ACCME.

CNE Credit (Nurses):
(Live activity) This continuing nursing education activity was approved by the New York State Nurses Association, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation.

It has been assigned approval code 82LJRN-10. 1.0 contact hours will be awarded upon successful completion.

(Archive activity) This continuing nursing education activity was approved by the New York State Nurses Association, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation.

It has been assigned approval code 82LJZ9-10. 1.0 contact hours will be awarded upon successful completion.

CEP Credit (Psychologists):
CME Outfitters is approved by the American Psychological Association to sponsor continuing education for psychologists. CME Outfitters maintains responsibility for this program and its content. (1.0 CE credits)

NASW Credit (Social Workers):
This program was approved by the National Association of Social Workers (provider #886407722) for 1 continuing education contact hour.

CCMC Credit (Certified Case Managers):
This program has been approved for 1 hour by the Commission for Case Manager Certification (CCMC).

CPE Credit (Pharmacists):
CME Outfitters, LLC, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 1.0 contact hours (0.1 CEUs)
Universal Activity Number:
376-999-10-006-L01-P (live presentation)
376-999-10-006-H01-P (recorded programs)
Activity Type: knowledge-based

Post-tests, credit request forms, and activity evaluations must be completed online at www.neuroscienceCME.com (click on the Testing/Certification link under the Activities tab� requires free account activation), and participants can print their certificate or statement of credit immediately (70% pass rate required). This website supports all browsers except Internet Explorer for Mac. For complete technical requirements and privacy policy, visit www.neurosciencecme.com/technical.asp.

This continuing education activity is co-sponsored by Indiana University School of Medicine and by CME Outfitters, LLC.

Disclosure Declaration

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Indiana University School of Medicine (IUSM) and CME Outfitters, LLC, (CMEO) must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, and planning committee members participating in activities sponsored by IUSM and CMEO are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
Note: While it offers CME credits, this activity is not intended to provide extensive training or certification in the field.

Dr. Harden has disclosed that she receives grants/research support from Forest Laboratories, Inc., GlaxoSmithKline, Pfizer Inc., and UCB Pharma. She has received honoraria from GlaxoSmithKline, Pfizer Inc., and UCB Pharma.

Professor Sperling has disclosed that he has received honoraria for speaking from GlaxoSmithKline, Pfizer Inc., and UCB Pharma. He has received honoraria for consulting from Dainippon Sumitomo Pharma Co., Ltd., and has received research support from H. Lundbeck A/S, Medtronic, Inc., Neuropace, Sepracor Inc., and UCB Pharma.

Dr. Salanova has no disclosures to report.

Unlabeled Use Disclosure

Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.

Indiana University School of Medicine, CME Outfitters, LLC, the faculty, and Pfizer Inc. do not endorse the use of any product outside of the FDA labeled indications. Medical professionals should not utilize the procedures, products, or diagnosis techniques discussed during this activity without evaluation of their patient for contraindications or dangers of use.

Questions about this activity? Call us at 877.CME.PROS (877.263.7767).

WC-009-032410-02